Metraipolis › archive › dc_4cecbc49cb8b

Prospective Evaluation of ESBL Risk Factors and Appropriateness of Empirical Therapy in Hospitalized Patients with Community-Onset Pyelonephritis — Europe PMC PMID:41750526

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41750526
DOI
10.3390/antibiotics15020229
License (as archived)
solo-consultazione
Archived
2026-11-05T15:00:58.861Z
SHA-256 of the archived text
24cf0cba629b2867af967dc7addd59a5a4931dde3d3f262a11c41d0244f2c894
Stable URL of this page
https://metraipolis.com/documento/dc_4cecbc49cb8b

How to cite

Prospective Evaluation of ESBL Risk Factors and Appropriateness of Empirical Therapy in Hospitalized Patients with Community-Onset Pyelonephritis — Europe PMC PMID:41750526 — Europe PMC (en), https://europepmc.org/article/MED/41750526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cecbc49cb8b (Metraipolis archive dc_4cecbc49cb8b, sha256 24cf0cba629b2867af967dc7addd59a5a4931dde3d3f262a11c41d0244f2c894)
BibTeX
@misc{dc4cecbc49cb8b,
  title = {Prospective Evaluation of ESBL Risk Factors and Appropriateness of Empirical Therapy in Hospitalized Patients with Community-Onset Pyelonephritis — Europe PMC PMID:41750526},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41750526},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cecbc49cb8b; sha256 24cf0cba629b2867af967dc7addd59a5a4931dde3d3f262a11c41d0244f2c894},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41750526. Agents can read the archived copy with the MCP tool read_document.